Automated Cell Line Control with Advanced PAT
Industry
Pharma / Biotech
Scope
Process Orchestration / PAT Modeling / Automation / Data Science
Timeframe
4 months
-
60%
experiment reduction time
-
80%
manual process steps removed
-
6
standalone equipments integrated
01
CLIENT
A leading biopharmaceutical innovator focused on advanced monoclonal antibody (MAb) production and the implementation of state-of-the-art perfusion bioprocessing.
02
BUSINESS NEEDS
The client aimed to build a state-of-the-art perfusion cell line for MAbs to increase overall product quality. This required deep collaboration with vendors to develop new Process Analytical Technology (PAT) methods and a thorough understanding of the commercialization potential of integrated lab setups.
03
CHALLENGE
To help our client achieve data unity, we overcame the following challenges:
-
Quality Management
Increasing product (MAb) quality by actively managing complex protein glycosylation profiles. -
Complex Automation
Automating a perfusion bioprocess that leverages advanced liquid chromatography and mass spectroscopy (LS/MS) PAT models. -
Interdisciplinary Coordination
Managing multiple streams of work across process research, data analytics, and system integration. -
Distributed Collaboration
Coordinating efforts across a distributed team located in multiple sites across the EU and USA.
04
SOLUTION
We delivered a fully integrated laboratory ecosystem that utilizes a central process orchestrator and closed-loop control to stabilize MAb glycosylation profiles. The solution entailed:
- Advanced Data Platform Creation of a centralized data platform with advanced visualization capabilities to monitor process parameters.
- Central Process Orchestration Implementation of a Process Orchestration Layer (POL) to manage the entire lab cell line.
- Closed-Loop Control Development of an automation framework based on integrated PAT models to enable real-time process adjustments.
- Team Integration Deployment of a specialized team of scientists, engineers, and technicians to handle complex technical requirements.
Achieving high-quality monoclonal antibody production at scale requires more than just advanced hardware; it demands the perfect orchestration of data, science, and automation. By integrating state-of-the-art LS/MS glycosylation profiling with a central Process Orchestration Layer, we moved from simple monitoring to true closed-loop control. This project highlights our ability to manage multiple complex workstreams, from deep process research to global system integration, ensuring that every technical hurdle is transformed into a quantifiable increase in product quality and operational efficiency.
Łukasz Paciorkowski
CEO A4BEE
Technology used
05
OUTCOME
The implementation successfully transformed a complex, manual research process into a fully integrated, high-precision bioprocessing environment. By closing the loop between analytical data and process control, we delivered a system capable of autonomous process parameters optimization.
- Real-Time Quality Assurance Active management of protein glycosylation profiles resulted in MAb consistency meeting the highest pharmaceutical standards.
- Operational Autonomy Transitioning to closed-loop automation reduced manual sampling, minimizing contamination risks and human error.
- Accelerated Research Harmonizing the lab cell line through a central orchestrator allowed for faster experiment iteration and reliable data correlation.
- Commercial Readiness Provided a scalable blueprint for perfusion bioprocessing, offering a clear path for global commercialization.
06
IMPLEMENTED SOLUTION
-
Automated Perfusion Control Real-time management of bioreactor parameters based on sampling data.
-
Aseptic Sampling Integration Seamless connection between the auto-sampler and analytical instruments.
-
PAT-Based Model Integration Using advanced data models to drive the Process Orchestration Layer.
-
Global Project Management Execution through a distributed EU/USA team across multiple work streams.
-
60%
experiment reduction time
-
80%
manual process steps removed
-
6
standalone equipments integrated